Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells

The development of multi-target drugs and irreversible modulators of deregulated signalling proteins is the major challenge for improving glioblastoma multiforme (GBM) treatment. Reversible single-target drugs are not sufficient to sustain a therapeutic effect over time and may favour the activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniele, Simona, Barresi, Elisabetta, Zappelli, Elisa, Marinelli, Luciana, Novellino, Ettore, Da Settimo, Federico, Taliani, Sabrina, Trincavelli, Maria L., Martini, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884960/
https://www.ncbi.nlm.nih.gov/pubmed/26761214
http://dx.doi.org/10.18632/oncotarget.6872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884960/
https://www.ncbi.nlm.nih.gov/pubmed/26761214
http://dx.doi.org/10.18632/oncotarget.6872

Ejemplares similares